Dr. Razavi graduated from the Medical College of Pennsylvania in 1995. He works in Houston, TX and specializes in Cardiovascular Disease and Clinical Cardiac Electrophysiology. Dr. Razavi is affiliated with Baylor St Lukes Medical Center and Select Specialty Hospital Houston Medical Center.
Medical School Isfahan Univ of Med Sci & Hlth Serv, Fac of Med, Isfahan, Iran Graduated: 1957
Conditions:
Aortic Valvular Disease Atrial Fibrillation and Atrial Flutter Congenital Anomalies of the Heart Diabetes Mellitus (DM) Disorders of Lipoid Metabolism
Languages:
English
Description:
Dr. Razavi graduated from the Isfahan Univ of Med Sci & Hlth Serv, Fac of Med, Isfahan, Iran in 1957. He works in Cleveland, OH and specializes in Cardiovascular Disease. Dr. Razavi is affiliated with Cleveland Clinic.
An apparatus comprises a sheathe for introducing a catheter into a blood vessel, a first electrode provided on the sheathe, a second electrode; and a measuring device to which the first and second electrodes are coupled. The measuring device measures the impedance or conduction velocity between the first electrode on the sheathe and the second electrode.
An apparatus comprises a sheath for introducing a catheter into a blood vessel, at least one electrode provided on the sheath, at least one other electrode; and a measuring device to which at least one pair of electrodes are coupled. The measuring device measures the impedance or conduction velocity between the first electrode on the sheath and the second electrode.
Sternal Closure Wire For Sensing And Therapeutic Energy Delivery
Mehdi Razavi - Houston TX, US Alan Brewer - Houston TX, US
Assignee:
Texas Heart Institute - Houston TX
International Classification:
A61N 1/00 A61B 5/04
US Classification:
607126, 600372, 600509, 607119, 607132
Abstract:
An embodiment includes a sensor coupled to a sternal closure wire. The sternal closure wire holds two sternum portions of a patient adjacent to one another and the first sensor senses a biological signal of the patient. An embodiment includes a current source coupled to a sternal closure wire. The sternal closure wire holds two sternum portions of a patient adjacent to one another, and the current source delivers an electrical current to the patient via the sternal closure wire. Other embodiments are described herein.
Predicting Chronic Optimal A-V Intervals For Biventricular Pacing Via Observed Inter-Atrial Delay
James A. Coles - Columbia MD, US Michael R. Ujhelyi - Maple Grove MN, US Mehdi Razavi - Houston TX, US Vadim Levin - Harleysville PA, US
International Classification:
A61N 1/05
US Classification:
607 9
Abstract:
Herein provided are methods for optimizing the atrio-ventricular (A-V) delay for efficacious delivery of cardiac resynchronization therapy. The A-V delay is set such that pacing-induced left ventricular contraction occurs following completion of left atrial (LA) contraction. This maximizes left ventricular filling (preload) which theoretically results in optimal LV contraction via the Frank-Starling mechanism. In CRT devices, the programmed A-V delay starts with detection of electrical activity in the right atrium (RA). Thus, a major component of the A-V delay is the time required for inter-atrial conduction time (IACT) from the RA to the LA. This IACT can be measured during implantation as the time from the atrial lead stimulation artifact to local electrograms in a coronary sinus (CS) catheter. Assuming that the beginning of LA contraction closely corresponds with the beginning of LA electrical activity, the optimal AV delay should be related to the time between the start of RA electrical activity and the start of LA electrical activity plus the duration of LA atrial contraction. Thus the inventors hypothesized that during atrial pacing the IACT measured at implantation correlated with the echocardiographically defined optimal paced AV delay (PAV).
Method And Device For Prevention Of Pneumothorax During Vascular Access
Methods and devices for prevention of a pneumothorax during vascular access are disclosed herein. The methods utilize a device having a detachable distal portion which serves to block the passageway created after a vascular access procedure. The device may include retention means to secure the device in the passageway. In addition, the methods may make use of tissue adhesives or glues to further ensure sealing of the passage. Furthermore, the disclosed methods and devices may be used to block perforations of blood vessels created during vascular access.
A vascular access device comprises a bridge having first and second bores therethrough, a dilator in the first bore, and a needle guide in the second bore. The second bore is at an angle with respect to the first bore such that the needle guide is at the angle with respect to the dilator. The device is useful, for example to achieve dual site entrance to a blood vessel.
Catheter With Electrodes For Impedance And/Or Conduction Velocity Measurement
An apparatus comprises a catheter comprising a first electrode. The apparatus also comprises a second electrode electrically attached to a person and coupled to the first electrode via the person's tissue. Logic is coupled to the electrodes and generates an electrical signal that is provided through the electrodes and computes an impedance or conduction velocity associated with the electrodes based on the electrical signal. The logic stores a threshold against which said computed impedance or conduction velocity is compared by said logic
Device, System, And Method For A Stress Sensing Medical Needle
MEHDI RAZAVI - Houston TX, US Gangbing Song - Pearland TX, US Alireza Nazeri - Houston TX, US Siu Chun Michael Ho - Sugor Land TX, US
International Classification:
A61B 6/00
US Classification:
600424
Abstract:
In an embodiment, an apparatus comprises a needle (e.g., hypodermic needle or trocar) and sensor (e.g., fiber Braggs grating sensor) coupled to a system to determine (e.g., in real time) stress and/or vibrations encountered by the needle. Consequently, various embodiments may (a) help identify nearby vessels, (b) determine whether the needle penetrated a hollow body structure, and (c) accurately guide needles towards a target structure (e.g., vessel). Other embodiments are described herein.
Name / Title
Company / Classification
Phones & Addresses
Mehdi Razavi DirectorVice-President
HALL - GARCIA CARDIOLOGY ASSOCIATES
6624 Fannin St STE 2480, Houston, TX 77030
Mehdi A. Razavi
Mehdi Razavi MD Cardiologist · Internist
6624 Fannin St, Houston, TX 77030 (713)5295530
Mehdi Razavi Director
MEDEFIX INC
1400 Mckinney St UNIT 1808, Houston, TX 77010 701 Brazos St, Austin, TX 78701 2433 Inwood Dr, Houston, TX 77019
Mehdi Razavi Director
ANONHX CORPORATION
1400 Mckinney St UNIT 1808, Houston, TX 77010 701 Brazos St, Austin, TX 78701 2433 Inwood, Houston, TX 77019
Mehdi Razavi Managing
Nanolinea, LLC
Mehdi Razavi Managing
RAZAVIM LLC
6624 Fannin St STE 2480 C/O DR MEDHI RAZAVI, Houston, TX 77030 800 Brazos St, Austin, TX 78701
Mehdi Razavi President, Director, Governing Person
Saranas Medical Devices · Mfg Surgical/Medical Instruments
6500 Main St #1020H, Houston, TX 77030 800 Brazos St STE 400, Austin, TX 78701 2450 Holcombe Blvd STE 8, Houston, TX 77021 2433 Inwood Dr, Houston, TX 77019
Maxwell Biomedical
Co-Founder
Rice University
Adjunct Associate Professor of Biongineering
Baylor College of Medicine
Associate Professor of Medicine
Saranas
Founder and Board Member
Nanolinea
Co-Founder
Education:
Mayo Clinic School of Health Sciences 1995 - 2002
Doctor of Medicine, Doctorates
University of Maryland Baltimore County 1991 - 1995
Bachelors, Bachelor of Science, Biology
Skills:
Clinical Research Healthcare Medical Devices Clinical Trials Cardiology Hospitals Medicine Surgery Medical Education Internal Medicine Research Biomedical Engineering Medical Research Start Ups Public Speaking Healthcare Information Technology Product Development Fda Lifesciences Clinical Development Healthcare Information Technology Cardiac Electrophysiology Healthcare Management U.s. Food and Drug Administration